Peptides for Women with Eating Disorders: Appetite Regulation

Written by Adam Maggio | Medically reviewed by Dr. James Whitfield, DO, FACOI

Eating disorders, prevalent in women, involve dysregulation of appetite hormones. .

Peptides for Women with Eating Disorders: Navigating Appetite and Satiety Signals

Eating disorders (EDs) are complex psychiatric conditions with severe medical and psychological consequences, disproportionately affecting women. These disorders manifest as distorted eating patterns, intense preoccupation with body weight and shape, and often co-occur with other mental health issues. The pathophysiology involves a intricate interplay of dysregulated appetite-regulating hormones, such as ghrelin, glucagon-like peptide-1 (GLP-1), cholecystokinin (CCK), and peptide YY (PYY), alongside neurotransmitter imbalances and profound psychological factors. Peptide therapies offer a nuanced approach to modulate these physiological signals, aiming to restore a healthier relationship with food and body.

Targeted Peptide Interventions for Eating Disorders

GLP-1 Receptor Agonists (e.g., Semaglutide, Tirzepatide): A Dual-Edged Sword

Glucagon-like peptide-1 (GLP-1) is an incretin hormone that plays a crucial role in glucose homeostasis, gastric emptying, and promoting satiety. GLP-1 receptor agonists (GLP-1 RAs) mimic these effects, leading to reduced appetite and significant weight loss [1, 2]. Emerging evidence suggests their potential utility in binge eating disorder (BED) and bulimia nervosa (BN) by reducing binge eating episodes and enhancing satiety [3, 4]. For instance, a meta-analysis of five studies (n=182) found significant improvements in Binge Eating Scale scores in those receiving GLP-1s [5]. However, their application demands extreme caution: their use in restrictive eating disorders like anorexia nervosa (AN) is contraindicated due to the significant risk of further weight loss and exacerbation of malnutrition [6, 7]. For weight management, semaglutide typically commences at 0.25 mg weekly, titrating up to 2.4 mg weekly. Tirzepatide starts at 2.5 mg weekly, escalating to 15 mg weekly. Dosing for EDs remains investigational and requires careful consideration within a multidisciplinary treatment framework.

Ghrelin Modulators: Targeting the Hunger Signal

Ghrelin, often dubbed the \\

Further research continues to elucidate the complex interplay of peptides in women's health. As our understanding deepens, personalized peptide protocols are becoming increasingly refined, offering tailored solutions for a wide array of conditions. The integration of these advanced therapies with conventional medical approaches holds significant promise for optimizing female well-being and longevity.

Further research continues to elucidate the complex interplay of peptides in women's health. As our understanding deepens, personalized peptide protocols are becoming increasingly refined, offering tailored solutions for a wide array of conditions. The integration of these advanced therapies with conventional medical approaches holds significant promise for optimizing female well-being and longevity.

Further research continues to elucidate the complex interplay of peptides in women's health. As our understanding deepens, personalized peptide protocols are becoming increasingly refined, offering tailored solutions for a wide array of conditions. The integration of these advanced therapies with conventional medical approaches holds significant promise for optimizing female well-being and longevity.

Further research continues to elucidate the complex interplay of peptides in women's health. As our understanding deepens, personalized peptide protocols are becoming increasingly refined, offering tailored solutions for a wide array of conditions. The integration of these advanced therapies with conventional medical approaches holds significant promise for optimizing female well-being and longevity.

Further research continues to elucidate the complex interplay of peptides in women's health. As our understanding deepens, personalized peptide protocols are becoming increasingly refined, offering tailored solutions for a wide array of conditions. The integration of these advanced therapies with conventional medical approaches holds significant promise for optimizing female well-being and longevity.

Further research continues to elucidate the complex interplay of peptides in women's health. As our understanding deepens, personalized peptide protocols are becoming increasingly refined, offering tailored solutions for a wide array of conditions. The integration of these advanced therapies with conventional medical approaches holds significant promise for optimizing female well-being and longevity.

Further research continues to elucidate the complex interplay of peptides in women's health. As our understanding deepens, personalized peptide protocols are becoming increasingly refined, offering tailored solutions for a wide array of conditions. The integration of these advanced therapies with conventional medical approaches holds significant promise for optimizing female well-being and longevity.

Further research continues to elucidate the complex interplay of peptides in women's health. As our understanding deepens, personalized peptide protocols are becoming increasingly refined, offering tailored solutions for a wide array of conditions. The integration of these advanced therapies with conventional medical approaches holds significant promise for optimizing female well-being and longevity.